The ups and downs of ecstasy

This publication has 19 references indexed in Scilit:

• Retraction
  Science, 2003
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
  Pharmacological Reviews, 2003
• RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")
  Science, 2002
• Caveat Emptor Editors Beware
  Neuropsychopharmacology, 2001
• Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers
  Neuropsychopharmacology, 1998
• Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers
  Neuropsychopharmacology, 1998
• The Psychopharmacology of Hallucinogens
  Neuropsychopharmacology, 1996
• Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations
  Behavioural Brain Research, 1995
• (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates
  JAMA, 1988
• Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration
  Brain Research, 1988